Business - Briefly   

U.S. FDA nod for JB Chemicals' API facility

MUMBAI: JB Chemicals & Pharmaceuticals' Panoli manufacturing facility in Gujarat has received the approval from the U.S. Food And Drug Administration for manufacturing active pharmaceutical ingredients (APIs) for the U.S. market. The U.S. FDA had conducted inspection of the company's facility in October 2003, based on which the approval was granted the company informed the Stock Exchange, Mumbai. — PTI

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

• Further amendments to ECB norms
• India, E.U. for resumption of WTO talks
• Drop three Singapore issues from WTO agenda — FICCI
• Cairn strikes huge oil reserves in Rajasthan
• M. V. Subbiah relinquishes office
• Increasing lines of credit to be routed via Exim Bank
• Equities stage smart recovery
• Board Meeting
• Rupee edges up
• CNG for urban cities
• Karnataka Power may take stake in Sikkim hydel
• Indian Rayon Q3 net at Rs. 28.5 cr.
• Bullion rates
• Exchange rates
• Stock Market Index
• Essar Oil allowed to go ahead with project
• PTC to go public in February
• Birla Sun hikes capital
• Thermax sets up subsidiary in Hong Kong
• Bose Corporation enters southern markets
• U.S. FDA nod for JB Chemicals' API facility

Copyright © 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu